Search for a report

Reports

  • You are here:
  • Home
  • Downloads
  • EUROPE OTC ARTIFICIAL TEARS MARKET FORECAST 2021-2028

EUROPE OTC ARTIFICIAL TEARS MARKET FORECAST 2021-2028

The Europe OTC artificial tears market is projected to register a CAGR of 4.78% over the estimated years of 2021 to 2028. The regional market’s growth is predominantly attributed to factors like the increasing technological advancements in the field of ophthalmology, the growing geriatric population, and the rising incidence of cataract surgeries.

EUROPE OTC ARTIFICIAL TEARS MARKET FORECAST 2021-2028

Europe OTC Artificial Tears Market by Formulation (Preservative Based, Non-preservative Based) Market by Product (Solution, Ointment, Gel, Spray Solution, Emulsion, Suspension) Market by Type of Container (Plastic Multi-dose Container, Plastic Single-dose Container, Spray) Market by Application (Dry Eye Syndrome, Allergies, Contact Lens Moisture Retention, Infections, Uv & Blue Light Protection, Other Applications) Market by Distribution Channel( Drug Stores & Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) by Geography

Request free sample

Report Summary

The Europe OTC artificial tears market is projected to register a CAGR of 4.78% over the estimated years of 2021 to 2028. The regional market’s growth is predominantly attributed to factors like the increasing technological advancements in the field of ophthalmology, the growing geriatric population, and the rising incidence of cataract surgeries.europe-otc-artificial-tears-market

To learn more about this report, request a free sample copy

The Europe OTC artificial tears market growth evaluation entails the assessment of Italy, the United Kingdom, Russia, Poland, France, Belgium, Germany, and the rest of Europe. The United Kingdom has been conducting numerous types of research in the avenue of dry eye disease, thereby facilitating the country’s overall market growth. For instance, scientists in the United Kingdom designed a smartphone application to tell a health professional whether the patient is suspected of having dry eye disease. Developed by researchers at Aston University in association with the United Kingdom’s industry, the application can be launched across pharmacies and general practitioners’ surgeries, in addition to being used at home.

In 2019, a Germany-based pharmaceutical company, Novaliq GmbH, partnered with Jiangsu Hengrui Medicine Co Ltd, China, to manufacture, develop, and commercialize water-free, innovative drugs, namely, CyclASol(R) and NOV03 for treating dry eye disease. Furthermore, this conjunction is set to benefit the market in China as well as Germany. Hence, these drivers are expected to reinforce the OTC artificial tears market growth in Europe during the forecasting period.

VISUfarma, headquartered in the Netherlands, is an eye health company and pan-European player commercializing a diverse portfolio of ophthalmic devices and products across international markets. It manages a unique network within the field of ophthalmology, enabling hospitals, doctors, and clinics to provide patients with the best eye care. Presently, the firm is active in five European nations, namely, Italy, Spain, the United Kingdom, Germany, and France.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    Table of Contents

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • PREVALENCE OF ALLERGIC CONJUNCTIVITIS AND DRY EYE DISEASE
        • PROGRESSIONS IN RESEARCH AND DEVELOPMENT IN THE OPTOMETRY SECTOR
        • SUSCEPTIBILITY OF GERIATRIC POPULATION TO EYE DISEASES
        • DEMAND FOR THE OTC ARTIFICIAL TEARS FOR THE TREATMENT OF PATIENTS
      • KEY RESTRAINTS
        • ACCESSIBILITY OF SUBSTITUTE THERAPIES
        • RISK OF SIDE EFFECTS RELATED TO THE OTC ARTIFICIAL TEARS DRUG
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON OTC ARTIFICIAL TEARS MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    2. MARKET BY FORMULATION
      • PRESERVATIVE BASED
      • NON-PRESERVATIVE BASED
    3. MARKET BY PRODUCT
      • SOLUTION
      • OINTMENT
      • GEL
      • SPRAY SOLUTION
      • EMULSION
      • SUSPENSION
    4. MARKET BY TYPE OF CONTAINER
      • PLASTIC MULTI-DOSE CONTAINER
        • PRESERVATIVE-FREE SYSTEM
        • PRESERVED SYSTEMS
      • PLASTIC SINGLE-DOSE CONTAINER
      • SPRAY
        • PRESERVED SYSTEMS
        • PRESERVATIVE-FREE SYSTEM
    1. MARKET BY APPLICATION
      • DRY EYE SYNDROME
      • ALLERGIES
      • CONTACT LENS MOISTURE RETENTION
      • INFECTIONS
      • UV & BLUE LIGHT PROTECTION
      • OTHER APPLICATIONS
    2. MARKET BY DISTRIBUTION CHANNEL
      • DRUG STORES & RETAIL PHARMACIES
      • HOSPITAL PHARMACIES
      • ONLINE PHARMACIES
    3. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • GERMANY
          • FRANCE
          • UNITED KINGDOM
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
      • COMPANY PROFILES
        • AKORN INC
        • ALCON INC
        • ALLERGAN PLC (ACQUIRED BY ABBVIE)
        • BAUSCH HEALTH COMPANIES INC
        • JOHNSON & JOHNSON
        • NICOX SA
        • NOVARTIS AG
        • OASIS MEDICAL
        • OCUSOFT INC
        • SANTEN PHARMACEUTICAL CO LTD
        • SENTISS PHARMA PVT LTD
        • SIMILASAN CORPORATION
        • SUN PHARMACEUTICAL INDUSTRIES LTD
        • URSAPHARM ARZNEIMITTEL GMBH
        • VISUFARMA

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – OTC ARTIFICIAL TEARS

    TABLE 2: EUROPE OTC ARTIFICIAL TEARS MARKET, BY FORMULATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: EUROPE OTC ARTIFICIAL TEARS MARKET, BY FORMULATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 4: EUROPE OTC ARTIFICIAL TEARS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: EUROPE OTC ARTIFICIAL TEARS MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 6: EUROPE OTC ARTIFICIAL TEARS MARKET, BY TYPE OF CONTAINER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: EUROPE OTC ARTIFICIAL TEARS MARKET, BY TYPE OF CONTAINER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: EUROPE PLASTIC MULTI-DOSE CONTAINER MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: EUROPE PLASTIC MULTI-DOSE CONTAINER MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: EUROPE SPRAY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 11: EUROPE SPRAY MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 12: EUROPE OTC ARTIFICIAL TEARS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 13: EUROPE OTC ARTIFICIAL TEARS MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 14: EUROPE OTC ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 15: EUROPE OTC ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 16: EUROPE OTC ARTIFICIAL TEARS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 17: EUROPE OTC ARTIFICIAL TEARS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 18: EUROPE OTC ARTIFICIAL TEARS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 19: EUROPE OTC ARTIFICIAL TEARS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 20: LEADING PLAYERS OPERATING IN THE EUROPE OTC ARTIFICIAL TEARS MARKET

    TABLE 21: LIST OF MERGERS & ACQUISITIONS

    TABLE 22: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 23: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 24: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: EUROPE OTC ARTIFICIAL TEARS MARKET, BY FORMULATION, IN 2020

    FIGURE 6: EUROPE OTC ARTIFICIAL TEARS MARKET, BY PRESERVATIVE BASED, 2021-2028 (IN $ MILLION)

    FIGURE 7: EUROPE OTC ARTIFICIAL TEARS MARKET, BY NON-PRESERVATIVE BASED, 2021-2028 (IN $ MILLION)

    FIGURE 8: EUROPE OTC ARTIFICIAL TEARS MARKET, BY PRODUCT, IN 2020

    FIGURE 9: EUROPE OTC ARTIFICIAL TEARS MARKET, BY SOLUTION, 2021-2028 (IN $ MILLION)

    FIGURE 10: EUROPE OTC ARTIFICIAL TEARS MARKET, BY OINTMENT, 2021-2028 (IN $ MILLION)

    FIGURE 11: EUROPE OTC ARTIFICIAL TEARS MARKET, BY GEL, 2021-2028 (IN $ MILLION)

    FIGURE 12: EUROPE OTC ARTIFICIAL TEARS MARKET, BY SPRAY SOLUTION, 2021-2028 (IN $ MILLION)

    FIGURE 13: EUROPE OTC ARTIFICIAL TEARS MARKET, BY EMULSION, 2021-2028 (IN $ MILLION)

    FIGURE 14: EUROPE OTC ARTIFICIAL TEARS MARKET, BY SUSPENSION, 2021-2028 (IN $ MILLION)

    FIGURE 15: EUROPE OTC ARTIFICIAL TEARS MARKET, BY TYPE OF CONTAINER, IN 2020

    FIGURE 16: EUROPE OTC ARTIFICIAL TEARS MARKET, BY PLASTIC MULTI-DOSE CONTAINER, 2021-2028 (IN $ MILLION)

    FIGURE 17: EUROPE PLASTIC MULTI-DOSE CONTAINER MARKET, BY PRESERVATIVE-FREE SYSTEM, 2021-2028 (IN $ MILLION)

    FIGURE 18: EUROPE PLASTIC MULTI-DOSE CONTAINER MARKET, BY PRESERVED SYSTEMS, 2021-2028 (IN $ MILLION)

    FIGURE 19: EUROPE OTC ARTIFICIAL TEARS MARKET, BY PLASTIC SINGLE-DOSE CONTAINER, 2021-2028 (IN $ MILLION)

    FIGURE 20: EUROPE OTC ARTIFICIAL TEARS MARKET, BY SPRAY, 2021-2028 (IN $ MILLION)

    FIGURE 21: EUROPE SPRAY MARKET, BY PRESERVED SYSTEMS, 2021-2028 (IN $ MILLION)

    FIGURE 22: EUROPE SPRAY MARKET, BY PRESERVATIVE-FREE SYSTEM, 2021-2028 (IN $ MILLION)

    FIGURE 23: EUROPE OTC ARTIFICIAL TEARS MARKET, BY APPLICATION, IN 2020

    FIGURE 24: EUROPE OTC ARTIFICIAL TEARS MARKET, BY DRY EYE SYNDROME, 2021-2028 (IN $ MILLION)

    FIGURE 25: EUROPE OTC ARTIFICIAL TEARS MARKET, BY ALLERGIES, 2021-2028 (IN $ MILLION)

    FIGURE 26: EUROPE OTC ARTIFICIAL TEARS MARKET, BY CONTACT LENS MOISTURE RETENTION, 2021-2028 (IN $ MILLION)

    FIGURE 27: EUROPE OTC ARTIFICIAL TEARS MARKET, BY INFECTIONS, 2021-2028 (IN $ MILLION)

    FIGURE 28: EUROPE OTC ARTIFICIAL TEARS MARKET, BY UV & BLUE LIGHT PROTECTION, 2021-2028 (IN $ MILLION)

    FIGURE 29: EUROPE OTC ARTIFICIAL TEARS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 30: EUROPE OTC ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, IN 2020

    FIGURE 31: EUROPE OTC ARTIFICIAL TEARS MARKET, BY DRUG STORES & RETAIL PHARMACIES, 2021-2028 (IN $ MILLION)

    FIGURE 32: EUROPE OTC ARTIFICIAL TEARS MARKET, BY HOSPITAL PHARMACIES, 2021-2028 (IN $ MILLION)

    FIGURE 33: EUROPE OTC ARTIFICIAL TEARS MARKET, BY ONLINE PHARMACIES, 2021-2028 (IN $ MILLION)

    FIGURE 34: EUROPE OTC ARTIFICIAL TEARS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 35: GERMANY OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 36: FRANCE OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 37: UNITED KINGDOM OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 38: ITALY OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 39: RUSSIA OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 40: BELGIUM OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 41: POLAND OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 42: REST OF EUROPE OTC ARTIFICIAL TEARS MARKET, 2021-2028 (IN $ MILLION)

    Segmentation

    1. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • GERMANY
          • FRANCE
          • UNITED KINGDOM
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. MARKET BY FORMULATION
      • PRESERVATIVE BASED
      • NON-PRESERVATIVE BASED
    2. MARKET BY PRODUCT
      • SOLUTION
      • OINTMENT
      • GEL
      • SPRAY SOLUTION
      • EMULSION
      • SUSPENSION
    3. MARKET BY TYPE OF CONTAINER
      • PLASTIC MULTI-DOSE CONTAINER
        • PRESERVATIVE-FREE SYSTEM
        • PRESERVED SYSTEMS
      • PLASTIC SINGLE-DOSE CONTAINER
      • SPRAY
        • PRESERVED SYSTEMS
        • PRESERVATIVE-FREE SYSTEM
    1. MARKET BY APPLICATION
      • DRY EYE SYNDROME
      • ALLERGIES
      • CONTACT LENS MOISTURE RETENTION
      • INFECTIONS
      • UV & BLUE LIGHT PROTECTION
      • OTHER APPLICATIONS
    2. MARKET BY DISTRIBUTION CHANNEL
      • DRUG STORES & RETAIL PHARMACIES
      • HOSPITAL PHARMACIES
      • ONLINE PHARMACIES

    Request Free Sample

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      RELATED REPORTS

      Author: Inkwood Research